Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.83 is 47% above its 5-year average of -3.47, around the middle of its 5-year range (-6.02–0.00).
33.09% above its 12-month average of -2.73.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 9 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.83
EARNINGS PER SHARE (EPS) AVG TTM
-2.73
EARNINGS PER SHARE (EPS) AVG 3Y
-3.73
EARNINGS PER SHARE (EPS) AVG 5Y
-3.47
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.09%
CURRENT VS 3Y AVG
+50.91%
CURRENT VS 5Y AVG
+47.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Rein Therapeutics Inc.
Market Cap
$22.97M
Earnings Per Share (EPS)
-1.83
TTM Avg
-2.73
3Y Avg
-3.73
5Y Avg
-3.47
Market Cap
$22.31M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$22.43M
Earnings Per Share (EPS)
-32.78
TTM Avg
-24.95
3Y Avg
-26.53
5Y Avg
-21.18
Market Cap
$24.38M
Earnings Per Share (EPS)
N/A
TTM Avg
22.45
3Y Avg
9.70
5Y Avg
5.59
Market Cap
$21.76M
Earnings Per Share (EPS)
-10.06
TTM Avg
-13.83
3Y Avg
-22.37
5Y Avg
-34.56
Market Cap
$24.67M
Earnings Per Share (EPS)
-4.34
TTM Avg
-3.52
3Y Avg
-3.45
5Y Avg
-7.67
Market Cap
$24.70M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$20.80M
Earnings Per Share (EPS)
-5.65
TTM Avg
-10.30
3Y Avg
-22.40
5Y Avg
-54.48
Market Cap
$25.38M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.19
3Y Avg
-0.10
5Y Avg
-0.07
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $22.97M | -1.83 | -2.73 | -3.73 | -3.47 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.31M | -1.66 | -1.66 | -2.82 | -25.82 |
| LeonaBio, Inc. (LONA)vs › | $22.43M | -32.78 | -24.95 | -26.53 | -21.18 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.38M | N/A | 22.45 | 9.70 | 5.59 |
| Modular Medical, Inc. (MODD)vs › | $21.76M | -10.06 | -13.83 | -22.37 | -34.56 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.67M | -4.34 | -3.52 | -3.45 | -7.67 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | -0.29 | -0.41 | -1.95 | -2.99 |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.80M | -5.65 | -10.30 | -22.40 | -54.48 |
| iTonic Holdings Ltd. (ITOC)vs › | $25.38M | N/A | -0.19 | -0.10 | -0.07 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.77M | -0.89 | -2.16 | -1.83 | -1.83 |
Trailing EPS (TTM)
$-1.83
Forward EPS (Est.)
$-0.46
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.96 |
| 2024-12-31 | -3.51 |
| 2023-12-31 | -3.42 |
| 2022-12-31 | -6.02 |
| 2021-12-31 | -5.89 |
| 2020-12-31 | 0.00 |
